Biogen Idec (Nasdaq: BIIB) develops and manufactures therapies in the Biotechnology industry.
Recent Mentions on Fool.com
- Based on This Study, an Alzheimer's Disease Cure Could Be Around the Corner
- Could These Experimental Drugs Eclipse Harvoni's Historic Launch?
- 3 Biotech Stocks to Buy If the Sector Crashes
- Biogen Idec Inc.'s Stock Bursts Higher On Alzheimer?s News: Here's Why
- Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?